
In its first treatment guidelines for patients with COVID-19, the National Institutes of Health says no specific therapy has yet been proven effective against the illness.
In its first treatment guidelines for patients with COVID-19, the National Institutes of Health says no specific therapy has yet been proven effective against the illness.
A daily COVID-19 update for Tuesday, April 21.
The CDC is calling for all adults to get tested for hepatitis C after the annual rate of infections tripled between 2009 and 2019.
New York City learned best practices to deal with coronavirus by observing outcomes in China, Italy and Seattle, but must continue to pay it forward for health care workers.
Should we be using N95 masks for all patients undergoing aerosol-generating procedures?
Whole genome sequencing revealed little overlap between MDROs found in pets and pet owners.
The US Centers for Disease Control and Prevention found early evidence that social distancing measures have had an impact on city’s efforts to combat the pandemic.
This test kit was developed to both increase the supply of COVID-19 tests for first responders and frontline health care workers who develop symptoms of COVID-19.
A daily round up of COVID-19 news.
Study authors conducted a meta-analysis to determine how prevalent loss of smell was as a predictor for COVID-19.
Investigators assure that effective treatment of COVID-19 can be found without losing scientific integrity and public confidence.
A new report finds positive trends in most categories of multidrug-resistant bacterial infections; however, the pathogens still cause more than half a million infections each year.
Oral third-generation cephalosporins failed to treat Shigella sonnei infections despite in vitro susceptibility in 4 cases.
Lucas Schulz, PharmD, BCPS, AQ-ID, discusses how he is preparing for COVID-19 as a clinical pharmacist working in Wisconsin.
Paul Blair, MD, MHS, MSPH, discusses the needs of frontline health care workers.
Over time we will learn the best utility of the ELISA test, as SARS-CoV-2 is here to stay.
Germany's National Academy of Sciences issued statements in March and April detailing necessary containment measures and a path to normalization.
Here is a look at infectious disease-related FDA news from the week of April 12, 2020.
We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:
Stay up to date with the latest COVID-19 news from Friday, April 17th.
The first phase allows states to ease lockdowns when they experience a 14-day downward trend in several COVID-19 indicators.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Deaths were reported among all age groups of health care personnel infected with COVID-19.
In a new editorial, 2 prominent physicians argue the incoming class of medical students ought to have their first year of medical school replaced with a year of public health service.
A new case of Ebola has been confirmed in the city of Beni in the Democratic Republic of the Congo.
A modelling study to forecast COVID-19 spread in China and inform decisions on relaxing restrictions, predicts a second wave that could require greater restrictions.
Rebecca Dutch, PhD, discusses misconceptions about the SARS-CoV-2 virus, how the virus differs from other coronaviruses, and critical information that remains unknown.
Stay up to date on the latest COVID-19 news from Thursday, April 16, 2020.
Tuberculosis is a threat to people living with HIV and finding preventive therapies that don’t cause interactions with antiretrovirals is a priority.
Pandemic preparedness and response plans should integrate public mental health interventions.